Global Ovarian Reserve Test 麻豆原创 Research Report 2023

Publication ID:

PB504236453

Publication Date:

May 16, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

Declining follicular pool and oocyte quality specially in the mid to late thirties.

This age-related decline of follicles in the human ovary is supposed to be more than double when numbers fall below a critical figure of 25,000 at ~37.5 years of age. According to World Health Organization (WHO), the number of women age 60 and over will increase from about 336 million in 2000 to just over 1 billion in 2050.

Moreover, safety and efficacy associated with ovarian reserve tests is likely to increase the demand in the near future. Manufacturers are also developing home testing kits for ovarian reserve test also provides easy accessibility and availability for checkups which is likely to rise the demand.

Ovarian surgeries also play an important role in driving the market, since removal of cysts can also result in diminished ovarian follicle in women. Thus, all these factors are likely to increase the market growth in the forecast period.
Highlights
The global Ovarian Reserve Test market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Ovarian Reserve Test is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Ovarian Reserve Test is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Ovarian Reserve Test in Hospitals is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Ovarian Reserve Test include Beckman Coulter, Fujirebio, F. Hoffmann-La Roche Ltd, Everlywell, LabCorp, VIDAS, Modern Fertility, Future Family and LetsGetChecked, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Ovarian Reserve Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ovarian Reserve Test.
The Ovarian Reserve Test market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Ovarian Reserve Test market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ovarian Reserve Test companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Beckman Coulter
Fujirebio
F. Hoffmann-La Roche Ltd
Everlywell
LabCorp
VIDAS
Modern Fertility
Future Family
LetsGetChecked
EggQ
Segment by Type
Follicle Stimulating Hormone (FSH) Testing
Anti-Mullerian hormone (AMH) Testing
Antral Follicle Count Testing
Basal Follicle Stimulating Hormone Testing
Segment by Application
Hospitals
IVF Centers
Diagnostic Centres
Ambulatory Surgical Centres
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ovarian Reserve Test companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Ovarian Reserve Test 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Follicle Stimulating Hormone (FSH) Testing
1.2.3 Anti-Mullerian hormone (AMH) Testing
1.2.4 Antral Follicle Count Testing
1.2.5 Basal Follicle Stimulating Hormone Testing
1.3 麻豆原创 by Application
1.3.1 Global Ovarian Reserve Test 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 IVF Centers
1.3.4 Diagnostic Centres
1.3.5 Ambulatory Surgical Centres
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Ovarian Reserve Test 麻豆原创 Perspective (2018-2029)
2.2 Ovarian Reserve Test Growth Trends by Region
2.2.1 Global Ovarian Reserve Test 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Ovarian Reserve Test Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Ovarian Reserve Test Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Ovarian Reserve Test 麻豆原创 Dynamics
2.3.1 Ovarian Reserve Test Industry Trends
2.3.2 Ovarian Reserve Test 麻豆原创 Drivers
2.3.3 Ovarian Reserve Test 麻豆原创 Challenges
2.3.4 Ovarian Reserve Test 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ovarian Reserve Test Players by Revenue
3.1.1 Global Top Ovarian Reserve Test Players by Revenue (2018-2023)
3.1.2 Global Ovarian Reserve Test Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Ovarian Reserve Test 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Ovarian Reserve Test Revenue
3.4 Global Ovarian Reserve Test 麻豆原创 Concentration Ratio
3.4.1 Global Ovarian Reserve Test 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ovarian Reserve Test Revenue in 2022
3.5 Ovarian Reserve Test Key Players Head office and Area Served
3.6 Key Players Ovarian Reserve Test Product Solution and Service
3.7 Date of Enter into Ovarian Reserve Test 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Ovarian Reserve Test Breakdown Data by Type
4.1 Global Ovarian Reserve Test Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Ovarian Reserve Test Forecasted 麻豆原创 Size by Type (2024-2029)
5 Ovarian Reserve Test Breakdown Data by Application
5.1 Global Ovarian Reserve Test Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Ovarian Reserve Test Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Ovarian Reserve Test 麻豆原创 Size (2018-2029)
6.2 North America Ovarian Reserve Test 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Ovarian Reserve Test 麻豆原创 Size by Country (2018-2023)
6.4 North America Ovarian Reserve Test 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Ovarian Reserve Test 麻豆原创 Size (2018-2029)
7.2 Europe Ovarian Reserve Test 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Ovarian Reserve Test 麻豆原创 Size by Country (2018-2023)
7.4 Europe Ovarian Reserve Test 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Ovarian Reserve Test 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Ovarian Reserve Test 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Ovarian Reserve Test 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Ovarian Reserve Test 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Ovarian Reserve Test 麻豆原创 Size (2018-2029)
9.2 Latin America Ovarian Reserve Test 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Ovarian Reserve Test 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Ovarian Reserve Test 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ovarian Reserve Test 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Ovarian Reserve Test 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Ovarian Reserve Test 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Ovarian Reserve Test 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Beckman Coulter
11.1.1 Beckman Coulter Company Detail
11.1.2 Beckman Coulter Business Overview
11.1.3 Beckman Coulter Ovarian Reserve Test Introduction
11.1.4 Beckman Coulter Revenue in Ovarian Reserve Test Business (2018-2023)
11.1.5 Beckman Coulter Recent Development
11.2 Fujirebio
11.2.1 Fujirebio Company Detail
11.2.2 Fujirebio Business Overview
11.2.3 Fujirebio Ovarian Reserve Test Introduction
11.2.4 Fujirebio Revenue in Ovarian Reserve Test Business (2018-2023)
11.2.5 Fujirebio Recent Development
11.3 F. Hoffmann-La Roche Ltd
11.3.1 F. Hoffmann-La Roche Ltd Company Detail
11.3.2 F. Hoffmann-La Roche Ltd Business Overview
11.3.3 F. Hoffmann-La Roche Ltd Ovarian Reserve Test Introduction
11.3.4 F. Hoffmann-La Roche Ltd Revenue in Ovarian Reserve Test Business (2018-2023)
11.3.5 F. Hoffmann-La Roche Ltd Recent Development
11.4 Everlywell
11.4.1 Everlywell Company Detail
11.4.2 Everlywell Business Overview
11.4.3 Everlywell Ovarian Reserve Test Introduction
11.4.4 Everlywell Revenue in Ovarian Reserve Test Business (2018-2023)
11.4.5 Everlywell Recent Development
11.5 LabCorp
11.5.1 LabCorp Company Detail
11.5.2 LabCorp Business Overview
11.5.3 LabCorp Ovarian Reserve Test Introduction
11.5.4 LabCorp Revenue in Ovarian Reserve Test Business (2018-2023)
11.5.5 LabCorp Recent Development
11.6 VIDAS
11.6.1 VIDAS Company Detail
11.6.2 VIDAS Business Overview
11.6.3 VIDAS Ovarian Reserve Test Introduction
11.6.4 VIDAS Revenue in Ovarian Reserve Test Business (2018-2023)
11.6.5 VIDAS Recent Development
11.7 Modern Fertility
11.7.1 Modern Fertility Company Detail
11.7.2 Modern Fertility Business Overview
11.7.3 Modern Fertility Ovarian Reserve Test Introduction
11.7.4 Modern Fertility Revenue in Ovarian Reserve Test Business (2018-2023)
11.7.5 Modern Fertility Recent Development
11.8 Future Family
11.8.1 Future Family Company Detail
11.8.2 Future Family Business Overview
11.8.3 Future Family Ovarian Reserve Test Introduction
11.8.4 Future Family Revenue in Ovarian Reserve Test Business (2018-2023)
11.8.5 Future Family Recent Development
11.9 LetsGetChecked
11.9.1 LetsGetChecked Company Detail
11.9.2 LetsGetChecked Business Overview
11.9.3 LetsGetChecked Ovarian Reserve Test Introduction
11.9.4 LetsGetChecked Revenue in Ovarian Reserve Test Business (2018-2023)
11.9.5 LetsGetChecked Recent Development
11.10 EggQ
11.10.1 EggQ Company Detail
11.10.2 EggQ Business Overview
11.10.3 EggQ Ovarian Reserve Test Introduction
11.10.4 EggQ Revenue in Ovarian Reserve Test Business (2018-2023)
11.10.5 EggQ Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Beckman Coulter
Fujirebio
F. Hoffmann-La Roche Ltd
Everlywell
LabCorp
VIDAS
Modern Fertility
Future Family
LetsGetChecked
EggQ

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.